199 related articles for article (PubMed ID: 34856383)
1. The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart.
Hoepfner J; Leonardy J; Lu D; Schmidt K; Hunkler HJ; Biß S; Foinquinos A; Xiao K; Regalla K; Ramanujam D; Engelhardt S; Bär C; Thum T
Mol Ther; 2022 Mar; 30(3):1265-1274. PubMed ID: 34856383
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA
Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1.
Yang R; Li L; Hou Y; Li Y; Zhang J; Yang N; Zhang Y; Ji W; Yu T; Lv L; Liang H; Li X; Li T; Shan H
Cell Death Dis; 2023 May; 14(5):344. PubMed ID: 37253771
[TBL] [Abstract][Full Text] [Related]
4. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
5. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
[TBL] [Abstract][Full Text] [Related]
6. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
Viereck J; Bührke A; Foinquinos A; Chatterjee S; Kleeberger JA; Xiao K; Janssen-Peters H; Batkai S; Ramanujam D; Kraft T; Cebotari S; Gueler F; Beyer AM; Schmitz J; Bräsen JH; Schmitto JD; Gyöngyösi M; Löser A; Hirt MN; Eschenhagen T; Engelhardt S; Bär C; Thum T
Eur Heart J; 2020 Sep; 41(36):3462-3474. PubMed ID: 32657324
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA Chast promotes cardiac remodeling.
Viereck J; Kumarswamy R; Foinquinos A; Xiao K; Avramopoulos P; Kunz M; Dittrich M; Maetzig T; Zimmer K; Remke J; Just A; Fendrich J; Scherf K; Bolesani E; Schambach A; Weidemann F; Zweigerdt R; de Windt LJ; Engelhardt S; Dandekar T; Batkai S; Thum T
Sci Transl Med; 2016 Feb; 8(326):326ra22. PubMed ID: 26888430
[TBL] [Abstract][Full Text] [Related]
8. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
[TBL] [Abstract][Full Text] [Related]
10. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
[TBL] [Abstract][Full Text] [Related]
12. lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth.
Li H; Trager LE; Liu X; Hastings MH; Xiao C; Guerra J; To S; Li G; Yeri A; Rodosthenous R; Silverman MG; Das S; Ambardekar AV; Bristow MR; González-Rosa JM; Rosenzweig A
Circulation; 2022 Apr; 145(16):1218-1233. PubMed ID: 35114812
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101.
Xiao L; Gu Y; Sun Y; Chen J; Wang X; Zhang Y; Gao L; Li L
J Cell Physiol; 2019 Aug; 234(8):13680-13692. PubMed ID: 30605239
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NRON alleviates atrial fibrosis through suppression of M1 macrophages activated by atrial myocytes.
Sun F; Guo Z; Zhang C; Che H; Gong W; Shen Z; Shi Y; Ge S
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693733
[TBL] [Abstract][Full Text] [Related]
18. LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway.
Xu L; Wang H; Jiang F; Sun H; Zhang D
Aging (Albany NY); 2020 Feb; 12(4):3126-3139. PubMed ID: 32087602
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y
PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
